These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 32123114)

  • 1. Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8
    Hermans D; Gautam S; García-Cañaveras JC; Gromer D; Mitra S; Spolski R; Li P; Christensen S; Nguyen R; Lin JX; Oh J; Du N; Veenbergen S; Fioravanti J; Ebina-Shibuya R; Bleck C; Neckers LM; Rabinowitz JD; Gattinoni L; Leonard WJ
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6047-6055. PubMed ID: 32123114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice.
    Klebanoff CA; Gattinoni L; Palmer DC; Muranski P; Ji Y; Hinrichs CS; Borman ZA; Kerkar SP; Scott CD; Finkelstein SE; Rosenberg SA; Restifo NP
    Clin Cancer Res; 2011 Aug; 17(16):5343-52. PubMed ID: 21737507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive Transfer of Interleukin-21-stimulated Human CD8+ T Memory Stem Cells Efficiently Inhibits Tumor Growth.
    Chen Y; Yu F; Jiang Y; Chen J; Wu K; Chen X; Lin Y; Zhang H; Li L; Zhang Y
    J Immunother; 2018; 41(6):274-283. PubMed ID: 29864078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Therapeutic Efficacy and Memory of Tumor-Specific CD8 T Cells by
    Abu Eid R; Ahmad S; Lin Y; Webb M; Berrong Z; Shrimali R; Kumai T; Ananth S; Rodriguez PC; Celis E; Janik J; Mkrtichyan M; Khleif SN
    Cancer Res; 2017 Aug; 77(15):4135-4145. PubMed ID: 28615225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
    Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
    Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced sensitivity to IL-2 signaling regulates the clinical responsiveness of IL-12-primed CD8(+) T cells in a melanoma model.
    Lisiero DN; Soto H; Liau LM; Prins RM
    J Immunol; 2011 May; 186(9):5068-77. PubMed ID: 21430221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 17 immunity promotes the exhaustion of CD8
    Kim BS; Kuen DS; Koh CH; Kim HD; Chang SH; Kim S; Jeon YK; Park YJ; Choi G; Kim J; Kang KW; Kim HY; Kang SJ; Hwang S; Shin EC; Kang CY; Dong C; Chung Y
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34083422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
    Dobrzanski MJ; Reome JB; Hollenbaugh JA; Dutton RW
    J Immunol; 2004 Feb; 172(3):1380-90. PubMed ID: 14734713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant metabolism regulates CD8+ T memory stem cell formation and antitumor immunity.
    Pilipow K; Scamardella E; Puccio S; Gautam S; De Paoli F; Mazza EM; De Simone G; Polletti S; Buccilli M; Zanon V; Di Lucia P; Iannacone M; Gattinoni L; Lugli E
    JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic LDH inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models.
    Verma S; Budhu S; Serganova I; Dong L; Mangarin LM; Khan JF; Bah MA; Assouvie A; Marouf Y; Schulze I; Zappasodi R; Wolchok JD; Merghoub T
    J Clin Invest; 2024 Sep; 134(17):. PubMed ID: 39225102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy.
    Hinrichs CS; Spolski R; Paulos CM; Gattinoni L; Kerstann KW; Palmer DC; Klebanoff CA; Rosenberg SA; Leonard WJ; Restifo NP
    Blood; 2008 Jun; 111(11):5326-33. PubMed ID: 18276844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcription factor c-Myb regulates CD8
    Gautam S; Fioravanti J; Zhu W; Le Gall JB; Brohawn P; Lacey NE; Hu J; Hocker JD; Hawk NV; Kapoor V; Telford WG; Gurusamy D; Yu Z; Bhandoola A; Xue HH; Roychoudhuri R; Higgs BW; Restifo NP; Bender TP; Ji Y; Gattinoni L
    Nat Immunol; 2019 Mar; 20(3):337-349. PubMed ID: 30778251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation.
    Pollizzi KN; Patel CH; Sun IH; Oh MH; Waickman AT; Wen J; Delgoffe GM; Powell JD
    J Clin Invest; 2015 May; 125(5):2090-108. PubMed ID: 25893604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potent vaccination strategy that circumvents lymphodepletion for effective antitumor adoptive T-cell therapy.
    Cho HI; Reyes-Vargas E; Delgado JC; Celis E
    Cancer Res; 2012 Apr; 72(8):1986-95. PubMed ID: 22367213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of IL-2- versus IL-15-stimulated CD8 T cells in adoptive immunotherapy.
    Mueller K; Schweier O; Pircher H
    Eur J Immunol; 2008 Oct; 38(10):2874-85. PubMed ID: 18825743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function.
    Zeng R; Spolski R; Finkelstein SE; Oh S; Kovanen PE; Hinrichs CS; Pise-Masison CA; Radonovich MF; Brady JN; Restifo NP; Berzofsky JA; Leonard WJ
    J Exp Med; 2005 Jan; 201(1):139-48. PubMed ID: 15630141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells.
    Liu Z; Liu JQ; Talebian F; Wu LC; Li S; Bai XF
    Eur J Immunol; 2013 Feb; 43(2):468-79. PubMed ID: 23225163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-Bet and Eomes Regulate the Balance between the Effector/Central Memory T Cells versus Memory Stem Like T Cells.
    Li G; Yang Q; Zhu Y; Wang HR; Chen X; Zhang X; Lu B
    PLoS One; 2013; 8(6):e67401. PubMed ID: 23826287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy.
    Alvarez-Fernández C; Escribà-Garcia L; Vidal S; Sierra J; Briones J
    J Transl Med; 2016 Jul; 14(1):214. PubMed ID: 27435312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.